Imaging in Coronary Interventions

Coronary angiography has historically served as the gold standard for diagnosis of coronary artery disease and guidance of percutaneous coronary intervention (PCI), but the evolution of PCI would not have been possible without intravascular imaging which provides unique insights about coronary artery pathology.

Over the last 30 years IVUS and, more recently, optical coherence tomography (OCT) have been extensively used to examine the extent and severity of coronary artery disease (CAD), guide PCI in complex lesions, and assess the performance of emerging devices introduced to treat CAD. In this section, you will find a selection of resources showing the use of imaging in real-life scenarios.

Filtered By
TOPICS

110 results

How to use intracoronary imaging and physiology to guide PCI in different scenarios

17 May 2023 – From EuroPCR 2023

What would you do in case of ACS with de novo left main bifurcation with ostial LAD ISR? How would you treat STEMI with MVD? What should be done when accidental abluminal POT navigates at LM? Watch this session to find out!

How to use intracoronary imaging and physiology to guide PCI in different scenarios

Stent failure management - The optimal use of intracoronary imaging - Part 1

17 May 2023 – From EuroPCR 2023

Watch this session to discover the optimal use of intracoronary imaging, to learn more about the differential role of IVUS and OCT imaging in stent failure, to study a case of in-stent restenosis due to calcified neoatherosclerosis, and to learn about the available evidence for the...

Stent failure management - The optimal use of intracoronary imaging - Part 1

How should I treat non-culprit lesions in a patient with STEMI

17 May 2023 – From EuroPCR 2023

You wonder whether complete revascularisation for STEMI patients is beneficial? You want to know how to assess non-culprit lesions? You wonder about the optimal timing for treating non-culprit lesions? You would like to be able to do more for STEMI patients? Then, this session replay is...

How should I treat non-culprit lesions in a patient with STEMI

The PECTUS trial, OCT for identification of vulnerable plaques and its impact on clinical outcomes

16 May 2023 – From EuroPCR 2023

Niels Van Royen and Lorenz Räber discuss a very emerging topic: the vulnerable plaque, and more specifically the related PECTUS Trial. They address the question of why vulnerable plaques should be detected and what can be done with the results, before looking at the study design...

The PECTUS trial, OCT

Management of complex non-culprit multivessel disease after STEMI - LIVE case

16 May 2023 – From EuroPCR 2023

Analyze the case of a 69-year-old non-diabetic male patient with mild chronic kidney disease, acute inferior MI and primary PCI on the postero-lateral RCA, whose angiography showed diffuse disease on the proximal CX and second OM (QFR: 0.65), and an intermediate prox LAD lesion (QFR: 0.90).

IVUS...

Management of complex non-culprit MVD after STEMI - LIVE case

Distal left main stenosis with a trifurcation - LIVE case

16 May 2023 – From EuroPCR 2023

Watch the case of a 69-year-old male patient with atrial fibrillation, peripheral artery disease and severe pulmonary disease, referred for worsening angina. The angiography revealed a tight distal left main stenosis on a trifurcation.

In this case, the PCI is guided by IVUS with provisional stenting (LM-LAD) and protect...

Distal left main stenosis with a trifurcation - LIVE case

Planning of CTO PCI based on initial angiogram

16 May 2023 – From EuroPCR 2023

View the case of a man with severe inferior ischemia and right coronary occlusion at the proximal and mi-parts, & follow discussion about how to approach the CTO, before analyzing the one of a 62-year-old man with anterior STEMI and elective PCI Cx, HTN, hyperlipidemia, LVEF...

Planning of CTO PCI based on initial angiogram

A patient with NSTEMI and multivessel disease: culprit and non-culprit lesion management

16 May 2023 – From EuroPCR 2023

Follow the discussion around 2 specific cases, a 72-year-old ex-smoker female patient with HTN, hyperlipidemia, previous TIA, COPD and stable lung cancer, and a 44-year-old male patient with T2DM, HTN, dyslipidemia, psoriasis and chest pain, and learn how to treat NSTEMI with MVD.

A patient with NSTEMI and multivessel disease: culprit and non-culprit lesion management

How can you determine the culprit lesion in NSTEMI?

16 May 2023 – From EuroPCR 2023

Since patients with NSTEMI represent an important population in practice, Ziad Ali and Natalia Pinilla discuss the diagnosis of culprit lesions in such patients. The first tool to rely on is intravascular imaging, even if imaging does not yet allow the interpretation of ambiguous or residual lesions....

How can you determine the culprit lesion in NSTEMI?

Results from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast reduction) Trial

16 May 2023 – From EuroPCR 2023

Javier Escaned joins Ajay Kirtane to discuss the DCR4C Trial he conducted, and more specifically to present the main results.

The framework of the study was the contrast reduction during PCI, which is closely related to what is now known as ultra-low contrast PCI, and which mainly concerns particularly...

Results from the DCR4Contrast